<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05077007</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU R 77/ 2021</org_study_id>
    <nct_id>NCT05077007</nct_id>
  </id_info>
  <brief_title>Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers</brief_title>
  <official_title>Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Science,Technology &amp; Innovation Funding Authority</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring&#xD;
      non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring&#xD;
      non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures and assess&#xD;
      their usefulness as diagnostic biomarkers for AKI and the relationship between the selected&#xD;
      RNA based biomarker panel and clinicopathological changes of patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 22, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of renal damage after PCNL and ESWL using novel RNA based Biomarkers</measure>
    <time_frame>Before the procedure by 2hours and after the procedure by 2 and 24 hours</time_frame>
    <description>Evaluation of kidney injury after procedures PCNL and ESWL by measuring the change of the level of novel non-coding lnc-RNA profile in urine</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Renal Calculi</condition>
  <condition>Percutaneous Nephrolithotomy</condition>
  <condition>Extracorporeal Shockwave Lithotripsy</condition>
  <arm_group>
    <arm_group_label>Percutaneous nephrolithotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients suffering of pelvic renal stones underwent Percutaneous nephrolithotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extracorporeal Shock Wave Lithotripsy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients suffering of pelvic renal stones underwent Extracorporeal Shock Wave Lithotripsy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Healthy volunteers with negative history of renal stones or renal impairment to measure the level of urinary markers in their urine samples</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous nephrolithotomy</intervention_name>
    <description>Endoscopic stone Extraction from the kidney by making a puncture and dilate a tract direct into the kidney through muscle wall and renal parenchyma</description>
    <arm_group_label>Percutaneous nephrolithotomy</arm_group_label>
    <other_name>PCNL</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extracorporeal Shock Wave Lithotripsy</intervention_name>
    <description>Using Shock waves from outside the body targeted at a kidney stone causing the stone to fragment. The stones are broken into tiny pieces.</description>
    <arm_group_label>Extracorporeal Shock Wave Lithotripsy</arm_group_label>
    <other_name>ESWL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inclusion criteria for patients :&#xD;
&#xD;
               1. Patients undergoing treatment for a stone(s) located in the kidney less than 2 cm&#xD;
&#xD;
               2. Radiopaque stone&#xD;
&#xD;
               3. Able and willing to give informed consent&#xD;
&#xD;
        Inclusion criteria for Healthy volunteers&#xD;
&#xD;
          1. No history of kidney or stone disease&#xD;
&#xD;
          2. Asymptomatic&#xD;
&#xD;
          3. No indwelling ureteral stent&#xD;
&#xD;
          4. Willing to provide medical history information&#xD;
&#xD;
          5. Able and willing to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusion criteria for patients&#xD;
&#xD;
               1. Active urinary tract infection&#xD;
&#xD;
               2. Bleeding disorder&#xD;
&#xD;
               3. Chronic renal failure (eGFR&lt;30)&#xD;
&#xD;
               4. Ureteral stone&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>waleed Mousa</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology Department, Ain Shams University, Abassia, Cairo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>waleed Mousa, MD</last_name>
    <phone>+201067628771</phone>
    <email>waleedmousa2@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed Tawfick, MD</last_name>
    <phone>+201223112243</phone>
    <email>murmer_urology26@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Urology Department, Faculty of Medicine, Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>11884</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>waleed Mousa, MD</last_name>
      <phone>01067628771</phone>
      <email>waleedmousa2@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>August 31, 2021</study_first_submitted>
  <study_first_submitted_qc>October 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 13, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lncRNA, mRNA, ESWL,PCNL,SBF2-AS1, FENDRR-19, NLRP3.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

